A world-leading and patented medical device, cleared by the FDA and TGA, to address an unmet medical need with the aim of improving the quality of life for sufferers of joint degeneration is now available in Australia.

From the elderly debilitated by pain due to osteoarthritis, to sportspeople affected by joint trauma, at least 30,000 patients worldwide have had their lives touched by this procedure as an alternative or supportive therapy to surgery, since 2014.

The device is a simple and effective proprietary technology to harvest, concentrate and deploy fat tissue in a single surgical step, for the application in regenerative medicine.

Now treating patients in Sydney and the Gold Coast.  More Australian locations opening soon.

* Treatment is not covered by Insurance or Medicare.